Information about the expected shortage of the medicinal product MST Continus 10 mg prolonged release tablets (morphine sulfate)
26.07.2012
Medis Adria d.o.o., the marketing authorisation holder for MST Continus 10 mg tablets with prolonged release (morphine sulfate) has informed the Agency for Medicinal Products and Medical Devices about the expected shortage of the aforementioned medicine on the Croatian market. This product has been used as a long term relief of postoperative and severe pain. The shortage is due to an increased consumption.
The normalisation of the market supply of the medicinal product MST Continus 10 mg prolonged release tablets is expected by the end of September 2012.
The public will be promptly informed of any new information about the shortage of the medicinal product MST Continus 10 mg prolonged release tablets.
